Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
When Katie Pollard, Ph.D., looks through a microscope, she often sees something familiar staring back. It's a unique population known as our microbiome -- the microbes that live in our stomachs and could potentially improve our health if we treat them right.
A disease with no cure that is linked to old age can be written off as simply inevitable. But we have a real opportunity to change that - and we are closer to doing so than ever before.
Gladstone bioninformatics expert Katie Pollard sits down with science and health innovators to discuss the future of medicine in the 21st century.
For video scroll to Wednesday, September 11th, "The New Diagnosis."
Gladstone's Deepak Srivastava comments on research in which scientists reprogram cells inside living mice -- and discover that the pluripotent stem cells created in the process are even more flexible than those derived from embryos or grown in laboratory dishes.
Are we on the cusp of curing HIV/AIDS? The Gladstone Institutes joins with leaders from CIRM, UCSF and others to engage the community in an interactive forum on cure research on October 1.
Gladstone researchers performed the feat using human cells in a laboratory dish.
Researchers have found a way to genetically reprogram scar tissue in the heart to make it behave like muscle tissue.
Scarred heart tissue can be transformed into beating cells using a cocktail of five genes, according to a new study.
Gladstone scientists have come a step closer to being able to repair the damage done by heart attacks, using a “cocktail of genes” to transform scar tissue into working heart muscles.
Heart disease, a leading cause of death in the U.S., costs billions, literally, in terms of services, medications, and lost productivity. Now, researchers have developed a new technique that “personalizes” treatment for those suffering from heart disease — a gene therapy approach that would be able to convert cells into heart muscle cells.